M ERT Pill - yellow capsule/oblong
Pill with imprint M ERT is Yellow, Capsule/Oblong and has been identified as Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg. It is supplied by Mylan Pharmaceuticals Inc.
Emtricitabine/rilpivirine/tenofovir disoproxil is used in the treatment of HIV Infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/rilpivirine/tenofovir disoproxil 200 mg / 25 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M ERT
Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Disoproxil Fumarate
- Imprint
- M ERT
- Strength
- 200 mg / 25 mg / 300 mg
- Color
- Yellow
- Shape
- Capsule/Oblong (film-coated, capsule shape)
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5440
Related images for "M ERT"
More about emtricitabine / rilpivirine / tenofovir disoproxil
- Check interactions
- Compare alternatives
- Reviews (60)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
Patient resources
- Emtricitabine, rilpivirine, and tenofovir drug information
- Emtricitabine, rilpivirine, and tenofovir (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.